Vertex to Participate in Upcoming Investor Conferences
21 February 2024 - 8:05AM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today
announced that Charles Wagner, Executive Vice President and Chief
Financial Officer, and David Altshuler, M.D., Ph.D., Executive Vice
President, Global Research, and Chief Scientific Officer, will
participate in two upcoming investor conferences:
- TD Cowen 44th Annual Health Care Conference on Tuesday, March
5, 2024 at 10:30 a.m. ET.
- Leerink Partners Global Biopharma Conference on Monday, March
11, 2024 at 4:00 p.m. ET.
A live webcast of management's remarks will be available through
the Vertex website, www.vrtx.com in the "Investors" section under
the "News and Events" page. A replay of the conference webcast will
be archived on the company's website.
About Vertex
Vertex is a global biotechnology company that invests in
scientific innovation to create transformative medicines for people
with serious diseases. The company has approved medicines that
treat the underlying causes of multiple chronic, life-shortening
genetic diseases — cystic fibrosis, sickle cell disease and
transfusion-dependent beta thalassemia — and continues to advance
clinical and research programs in these diseases. Vertex also has a
robust clinical pipeline of investigational therapies across a
range of modalities in other serious diseases where it has deep
insight into causal human biology, including APOL1-mediated kidney
disease, acute and neuropathic pain, type 1 diabetes, myotonic
dystrophy type 1 and alpha-1 antitrypsin deficiency.
Vertex was founded in 1989 and has its global headquarters in
Boston, with international headquarters in London. Additionally,
the company has research and development sites and commercial
offices in North America, Europe, Australia, Latin America and the
Middle East. Vertex is consistently recognized as one of the
industry's top places to work, including 14 consecutive years on
Science magazine's Top Employers list and one of Fortune’s 100 Best
Companies to Work For. For company updates and to learn more about
Vertex's history of innovation, visit www.vrtx.com or follow us on
LinkedIn, YouTube and Twitter/X.
(VRTX-WEB)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240220983064/en/
Vertex Pharmaceuticals Incorporated Investor Relations:
InvestorInfos@vrtx.com
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Apr 2024 to May 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From May 2023 to May 2024